To elucidate the involvement of MYO6 mutations, known to be responsible for DFNA22/DFNB37, in Japanese hearing loss patients through the use of genetic analysis.
Methods:
Genomic variations responsible for hearing loss were identified by massively parallel DNA sequencing (MPS) of 63 target candidate genes in 1120 Japanese hearing loss patients, and the detailed clinical features for the patients with MYO6 mutations were collected and analyzed.
Results:
Four mutations were successfully found in 7 families exhibiting autosomal dominant inheritance. All of the patients showed progressive hearing loss, but hearing type and onset age varied. Further, none of the affected patients showed any associated symptoms, such as hypertrophic cardiomyopathy or retinitis pigmentosa.
Conclusions:
MPS is powerful tool for the identification of rare causative deafness gene mutations, such as MYO6. The clinical characteristics noted in the present study not only confirmed the findings of previous reports but provided important new clinical information.
Van CampGWillemsPJSmithRJ. Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet. 1997;60:758-764.
2.
MelchiondaSAhituvNBiscegliaL, et al. MYO6, the human homologue of the gene responsible for deafness in Snell’s waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am J Hum Genet. 2001;69:635-640.
3.
AhmedZMMorellRJRiazuddinS, et al. Mutations of MYO6 are associated with recessive deafness, DFNB37. Am J Hum Genet. 2003;72:1315-1322.
4.
HassonT. Myosin VI: two distinct roles in endocytosis. J Cell Sci. 2003;116:3453-3461.
5.
HassonTGillespiePGGarciaJA, et al. Unconventional myosins in inner-ear sensory epithelia. J Cell Biol. 1997;137:1287-1307.
6.
FriedmanTBSellersJRAvrahamKB. Unconventional myosins and the genetics of hearing loss. Am J Med Genet. 1999;89:147-157.
7.
SelfTSobeTCopelandNGJenkinsNAAvrahamKBSteelKP. Role of myosin VI in the differentiation of cochlear hair cells. Dev Biol. 1999;214:331-341.
8.
AvrahamKBHassonTSteelKP, et al. The mouse Snell’s waltzer deafness gene encodes an unconventional myosin required for structural integrity of inner ear hair cells. Nat Genet. 1995;11:369-375.
9.
MiyagawaMNaitoTNishioSYKamataniNUsamiS. Targeted exon sequencing successfully discovers rare causative genes and clarifies the molecular epidemiology of Japanese deafness patients. PLoS One. 2013;8:e71381.
10.
MiyagawaMNishioSYIkedaTFukushimaKUsamiS. Massively parallel DNA sequencing successfully identifies new causative mutations in deafness genes in patients with cochlear implantation and EAS. PLoS One. 2013;8:e75793.
11.
ChangXWangK. wANNOVAR; annotating genetic variants for personal genomes via the web. J Med Genet. 2012;49:433-436.
12.
WangKLiMHakonarsonH. ANNOVAR: functional annotation of genetic variation from high-throughput sequencing data. Nucleic Acid Res. 2010;38:e164.
13.
AbecasisGRAutonABrooksLD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature2012;491(7422):56-65.
NaraharaMHigasaKNakamuraS, et al. Large-scale East-Asian eQTL mapping reveals novel candidate genes for LD mapping and the genomic landscape of transcriptional effects of sequence variants. PLoS One. 2014;9(6):e100924.
16.
PollardKSHubiszMJRosenbloomKR, et al. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 2010;20(1):110-121.
17.
KumarPHenikoffSNgPC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073-1081.
18.
AdzhubeiIASchmidtSPeshkinL, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248-249.
19.
ChunSFayJC. Identification of deleterious mutations within three human genomes. Genome Res. 2009;19(9):1553-1561.
20.
SchwarzJMRodelspergerCSchuelkeM, et al. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575-576.
21.
CooperGMStoneEAAsimenosG, et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 2005;15(7):901-913.
22.
KwonTJOhSKParkHJ, et al. The effect of novel mutations on the structure and enzymatic activity of unconventional myosins associated with autosomal dominant non-syndromic hearing loss. Open Biol. 2014;4:140107.
23.
MohiddinSAAhmedZMGriffithAJ, et al. Novel association of hypertrophic cardiomyopathy, sensorineural deafness, and a mutation in unconventional myosin VI (MYO6). J Med Genet. 2004;41:309-314.
24.
SanggaardKMKjaerKWEibergH, et al. A novel nonsense mutation in MYO6 is associated with progressive nonsyndromic hearing loss in a Danish DFNA22 family. Am J Med Genet A. 2008;146A:1017-1025.
25.
OonkAMLeijendeckersJMLammersEM, et al. Progressive hereditary hearing impairment caused by a MYO6 mutation resembles presbyacusis. Hear Res. 2013;299:88-98.
26.
BrecklerJAuKChengJHassonTBurnsideB. Novel myosin VI isoform is abundantly expressed in retina. Exp Eye Res. 2000;70:121-134.
27.
ChoiBYParkGGimJ, et al. Diagnostic application of targeted resequencing for familial nonsyndromic hearing loss. PLoS One. 2013;8:e68692.
28.
ShearerAEDeLucaAPHildebrandMS, et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA. 2010;107:21104-21109.
29.
VonaBMüllerTNandaI, et al. Targeted next-generation sequencing of deafness genes in hearing-impaired individuals uncovers informative mutations. Genet Med. 2014;16:945-953.
30.
MelchiondaSAhituvNBiscegliaL, et al. MYO6, the human homologue of the gene responsible for deafness in Snell’s waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am J Hum Genet. 2001;69:635-640.
31.
HilgertNTopsakalVvan DintherJOffeciersEVan de HeyningPVan CampG. A splice-site mutation and overexpression of MYO6 cause a similar phenotype in two families with autosomal dominant hearing loss. Eur J Hum Genet. 2008;16:593-602.
32.
YangTWeiXChaiYLiLWuH. Genetic etiology study of the non-syndromic deafness in Chinese Hans by targeted next-generation sequencing. Orphanet J Rare Dis. 2013;8:85.
